Thermo Fisher Reports Strong Q1 Results with $11.01B Revenue, $5.44 Adjusted EPS, Completes Acquisition, and Repurchases $3B Stock
TMO sits 30% above its 52-week low of $385.46.
Summary
Thermo Fisher Scientific announced strong first-quarter 2026 financial results, including $11.01 billion in revenue and $5.44 adjusted EPS, alongside the completion of a strategic acquisition, a $3.0 billion stock repurchase, and a 10% dividend increase.
Key Events · Earnings and Guidance · TMO
-
Strong Q1 Financial Performance
First quarter revenue grew 6% to $11.01 billion, with adjusted diluted EPS increasing 6% to $5.44. GAAP diluted EPS grew 11% to $4.43.
-
Significant Share Repurchase
The company repurchased $3.0 billion of its common stock during the quarter, demonstrating a commitment to returning capital to shareholders.
-
Dividend Increase Announced
Thermo Fisher Scientific increased its quarterly dividend by 10%, reflecting confidence in its financial health and future prospects.
-
Strategic Acquisition Completed
The acquisition of Clario, an industry-leading provider of endpoint data solutions, was completed during the quarter, enhancing the company's capabilities.
Analysis · TMO · Industrial Applications And Services
Thermo Fisher Scientific delivered a strong start to the year, reporting solid first-quarter financial results that align with the positive news released earlier today. The company's 6% revenue growth and 6% adjusted EPS growth demonstrate consistent operational performance. The completion of the Clario acquisition strengthens its strategic position, while the significant $3.0 billion stock repurchase and 10% dividend increase signal robust capital allocation and confidence in future cash flows. Investors will now focus on the updated 2026 financial guidance to be provided during the earnings call.
At the time of this filing, TMO was trading at $499.39 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $191B. The 52-week trading range was $385.46 to $643.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.